ABOUT
We provide more than just physics. Our unique approach combines attention to detail while catering to clients’ needs. With decades of board-certified clinical experience and routine attendance at our professional society meetings, we adhere to deliverables and timelines without compromising quality or disrupting your clinic. Our client relationship starts well before a project and lasts well beyond. Other large consulting companies seek clients. We seek client satisfaction.
Matthew Witten, PhD, DABR
Board-certified in the subspecialty of Therapeutic Medical Physics, he earned his doctoral degree from Columbia University and has over twenty years of clinical experience, working in diverse settings. He has commissioned linear accelerators manufactured by all major vendors, and has set up clinical programs for many different treatment modalities, including HDR, IMRT, IGRT, IORT, and SRS/SBRT. His current area of specialization is CyberKnife, including the MLC M6 system, and he is responsible for the creation, operation, and oversight of a program with two active systems. His research interests include evolutionary computation in treatment planning optimization, an area in which he jointly holds a patent with Dr. Owen Clancey, and the theory of uncertainty in the context of the creation of best practices for reducing the probability of medical errors.
Owen Clancey, PhD, DABR
Board-certified in the subspecialty of Therapeutic Medical Physics and with a doctoral degree from Columbia University, he has over 10 years of clinical experience ranging from commissioning new linear accelerators to program implementation and improvement of varying modalities, including HDR, IMRT, IGRT, and SRS/SBRT. He currently specializes in CyberKnife, including the MLC M6 system, and is directly responsible for two active systems. Other emphasized areas of interest include clinical efficiency through technology-driven and process-oriented workflows and theory and data driven methods for error reduction. His research interests include large-scale treatment planning optimization, and he jointly holds a patent with Dr. Matthew Witten.